Skip to content

Medical emergency? What to do

New cancer drugs could help in autoimmune disease

3-RXPublished October 9, 20072 min read

Key points

  • A new class of drugs used to treat cancer might be effective at suppressing overactive immune systems in patients with autoimmune diseases like Crohn's disease, U.S. researchers said on Sunday.
  • Hancock said drugs known as histone deacetylases inhibitors, or HDACs, which affect compounds involved in the growth and death of cancer cells, bolstered the production of cells that regulate the immune system in mice.
  • These transplants are currently given to some type 1 diabetics, whose natural insulin-producing islet cells have been destroyed by the disease.
  • "In most animals, if we gave them an HDAC inhibitor, we were able to enhance T-regulatory function and suppress rejection and induce long-term graft survival," he said in a telephone interview.

A new class of drugs used to treat cancer might be effective at suppressing overactive immune systems in patients with autoimmune diseases like Crohn's disease, U.S. researchers said on Sunday.

"What we would be proposing would be a therapy that would enhance the body's own immune system's ability to regulate itself," said Wayne Hancock of Children's Hospital of Philadelphia, whose study appears in the journal Nature Medicine.

Hancock said drugs known as histone deacetylases inhibitors, or HDACs, which affect compounds involved in the growth and death of cancer cells, bolstered the production of cells that regulate the immune system in mice.

In one study, the drug helped reverse and prevent inflammatory bowel disease. It also prevented the rejection of heart transplants in other mice. And it stopped rejection of pancreatic cell transplants in other mice.

These transplants are currently given to some type 1 diabetics, whose natural insulin-producing islet cells have been destroyed by the disease.

Islet-cell transplants often fail after a year. But Hancock thinks therapies using HDAC drugs might be able to prevent this.

"In most animals, if we gave them an HDAC inhibitor, we were able to enhance T-regulatory function and suppress rejection and induce long-term graft survival," he said in a telephone interview.

While many companies are working on HDACs, Hancock's study focused on the Merck & Co Inc drug Zolinza, also known by its chemical name suberoylanilide hydroxamic acid, or SAHA.

Zolinza is approved in the United States to treat cutaneous T cell lymphoma, a type of skin cancer.

Hancock said SAHA appears to bolster the work of regulatory T-cells that suppress the immune system. "Their job is to act as police and dampen down inflammatory responses," he said.

The study offers evidence that a drug could be used to enhance regulatory T-cell production and function. "That hadn't been done before," Hancock said.

He and colleagues are working with researchers in Minnesota to try the Merck drug Zolinza in diabetic monkeys with islet cell transplants.

Hancock said the drugs have the potential to treat other autoimmune ses, like rheumatoid arthritis.

So far, they are mostly being studied in cancer, but that could change.

"I image a number of companies who have been developing these compounds for oncology will pick up their ears when they hear this," he said.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. Drug information pages are an archive and may be out of date: always follow your prescriber, your pharmacist and the current product label. In an emergency, call 911.

Filed underCancerDrug News

Keep reading

Drug News

Fungus-fighting drug may make mild flu meaner

Mice given a drug commonly used in patients to fight systemic fungal infections more often succumb to what would otherwise be a mild case of the flu. The evidence reported in the Cell Press journal Cell Reports on…

2 min read

When to get help

Reading is for later. These need care now.

Call 911 or go to an emergency department if you or someone with you has any of these:

  • Chest pain or pressureEspecially with breathlessness, sweating or pain in the arm, jaw or back. It can be a heart attack.
  • Face drooping, arm weakness, slurred speechSigns of a stroke. Note the time they started: treatment works best within hours.
  • Severe trouble breathingIncluding a severe allergic reaction with swelling of the lips, tongue or throat.
  • Thoughts of suicideCall or text 988 (Suicide & Crisis Lifeline, US) any time, day or night.

Outside the US, call your local emergency number.

See a doctor within days

  1. 01A new lump, or a sore that does not healMost lumps are harmless, but anything that grows or lasts more than a few weeks should be checked.
  2. 02Unexplained weight loss or lasting fatigueLosing weight without trying, or tiredness that does not lift, can have many causes worth finding.
  3. 03A new medicine and new symptomsSide effects and interactions are common. Ask your pharmacist or prescriber before you stop anything.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.